May 29, 2025 (Amgen Inc. (via LinkedIn)) –
Amgen Inc. posted 31 LinkedIn updates from May 22 to May 29, 2025. The company's posts covered a wide range of topics, including innovative medical research, global health initiatives, corporate social responsibility, and employee recognition. Let's delve into the key areas of focus for Amgen during this period.
Medical Research and Patient Care
Amgen demonstrated its commitment to advancing medical research and improving patient care across various therapeutic areas. The company highlighted its efforts in addressing rare diseases, autoimmune conditions, and cancer treatment. A significant focus was placed on Thyroid Eye Disease (TED), also known as Graves' orbitopathy, with multiple posts raising awareness about this rare condition and its symptoms.
In oncology, Amgen announced its participation in the upcoming ASCO Annual Meeting in Chicago, where the latest advancements in clinical trials, precision medicine, targeted therapies, and immunotherapy will be presented. The company emphasized its focus on gastrointestinal and lung tumors, showcasing its dedication to pushing the boundaries of cancer research.
TED awareness in German market
ASCO 2025 participation announcement
TED awareness for Vision Health Month
Global Health Initiatives and Partnerships
Amgen's global reach was evident in several posts highlighting international collaborations and health initiatives. The company supported the creation of the Greek Rare Disease Map, a tool providing vital information and care resources for patients with rare diseases in Greece. In Brazil, Amgen participated in the 17th CBOOM (Brazilian Orthopedic Congress of Osteometabolism), reinforcing its commitment to bone health research and medical education.
The company also showcased its involvement in the Amgen Scholars Program, partnering with the University of Toronto to provide undergraduate students with research opportunities in biomedical sciences. This initiative demonstrates Amgen's dedication to nurturing the next generation of scientific talent.
Greek Rare Disease Map initiative
Participation in CBOOM in Brazil
Amgen Scholars Program at University of Toronto
Innovation and Commercial Success
Amgen highlighted its U.S. Commercial Team's role in bringing innovative medicines to patients. The company emphasized how this team builds partnerships with practitioners, helps them understand treatment options, and works on delivery solutions to transform scientific discoveries into real-world impact for patients.
In a showcase of innovation, Amgen featured a startup called hikeOn, which is developing a smart bracelet to improve mobility and reduce falls in Parkinson's patients. This collaboration demonstrates Amgen's interest in supporting novel technologies that can significantly impact patient care.
U.S. Commercial Team's role in patient care
Collaboration with hikeOn startup
Corporate Social Responsibility and Employee Engagement
Amgen showcased its commitment to corporate social responsibility and employee well-being through various initiatives. The company celebrated International HR Day, recognizing the crucial role of its HR team in supporting employees and shaping a thriving workplace. Amgen also highlighted its "Walk to Wellness 2025" challenge, promoting employee health and team building.
The company's focus on diversity and inclusion was evident in a post about its recognition by Great Place To Work in Mexico, where 97% of employees reported feeling treated fairly regardless of gender. Amgen also celebrated the success of four women from its Ireland office who were recognized at the Women In Pharma Awards.
International HR Day celebration
Walk to Wellness 2025 challenge
Women In Pharma Awards recognition
Other Noteworthy Updates
Amgen also shared updates on its internship program, encouraging students to apply for meaningful roles within the company. The company continued to raise awareness about various health conditions, including heart disease and its risk factors, demonstrating its commitment to public health education.
In conclusion, Amgen's LinkedIn activity during this period showcases a company deeply committed to medical innovation, global health initiatives, and employee well-being. From groundbreaking research in oncology and rare diseases to fostering a diverse and inclusive workplace, Amgen continues to position itself as a leader in the biotechnology industry, driving positive change on a global scale.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistribute or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.